Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation

Autor: Andrew E. Leitch, John A. Marwick, Rodger Duffin, Adriano G. Rossi, Christopher D. Lucas, Christopher Haslett
Jazyk: angličtina
Rok vydání: 2012
Předmět:
DOWN-REGULATION
Transcription
Genetic

Neutrophils
LIPOPOLYSACCHARIDE
0302 clinical medicine
AGING NEUTROPHILS
Phosphorylation
MACROPHAGES
P-TEFb
0303 health sciences
biology
Kinase
apoptosis
neutrophil
Hep G2 Cells
Cyclin-Dependent Kinases
3. Good health
Cell biology
cyclin-dependent kinase
030220 oncology & carcinogenesis
RNA Polymerase II
Programmed cell death
RNA-POLYMERASE-II
HL-60 Cells
03 medical and health sciences
Cyclin-dependent kinase
Roscovitine
Humans
Protein Kinase Inhibitors
Molecular Biology
030304 developmental biology
Inflammation
Original Paper
INTERFERON-GAMMA
resolution
IN-VITRO
Cell Biology
Cyclin-Dependent Kinase 9
P-TEFB
CELL-DEATH
Purines
Apoptosis
inflammation
biology.protein
Cyclin-dependent kinase 9
Cyclin-dependent kinase 7
MCL-1
Dichlororibofuranosylbenzimidazole
Cyclin-Dependent Kinase-Activating Kinase
CDK inhibitor
Zdroj: Leitch, A E, Lucas, C, Marwick, J A, Duffin, R, Haslett, C & Rossi, A G 2012, ' Cyclin-dependent kinases 7 and 9 specifically regulate neutrophil transcription and their inhibition drives apoptosis to promote resolution of inflammation ', Cell Death and Differentiation, vol. 19, no. 12, pp. 1950-1961 . https://doi.org/10.1038/cdd.2012.80
Cell Death and Differentiation
DOI: 10.1038/cdd.2012.80
Popis: Terminally differentiated neutrophils are short-lived but the key effector cells of the innate immune response, and have a prominent role in the pathogenesis and propagation of many inflammatory diseases. Delayed apoptosis, which is responsible for their extended longevity, is critically dependent on a balance of intracellular survival versus pro-apoptotic proteins. Here, we elucidate the mechanism by which the cyclin-dependent kinase (CDK) inhibitor drugs such as R-roscovitine and DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) mediate neutrophil apoptosis. We demonstrate (by a combination of microarray, confocal microscopy, apoptosis assays and western blotting) that the phosphorylation of RNA polymerase II by CDKs 7 and 9 is inhibited by R-roscovitine and that specific effects on neutrophil transcriptional capacity are responsible for neutrophil apoptosis. Finally, we show that specific CDK7 and 9 inhibition with DRB drives resolution of neutrophil-dominant inflammation. Thus, we highlight a novel mechanism that controls both primary human neutrophil transcription and apoptosis that could be targeted by selective CDK inhibitor drugs to resolve established inflammation.Cell Death and Differentiation advance online publication, 29 June 2012; doi:10.1038/cdd.2012.80.
Databáze: OpenAIRE